{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:45Z","timestamp":1772165685621,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Detection of COVID-19 in cancer patients is challenging due to probable preexisting pulmonary infiltration caused by many infectious and non-infectious etiologies. We evaluated chest CT scan findings of COVID-19 pneumonia in cancer patients and explored its prognostic role in mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied 266 COVID-19 patients with a history of cancer diagnosis between 2020 and 2022. Chest CT images were reported based on Radiological Society of North America (RSNA) structural report and the CT score and pattern of involvement were noted. We used multivariate logistic regression models to determine the association between CT scan findings and mortality of the cancer COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age was 56.48 (\u00b1\u200918.59), and 53% were men. Gastrointestinal (29.3%), hematologic (26.3%), and breast (10.5%) cancers were the most frequent types of cancer. The prevalence of atypical or indeterminate findings in the chest CT was 42.8%. Most radiologic findings were consolidation mixed with ground-glass opacity (44.4%), pleural effusion (33.5%), and pure ground-glass opacity (19.5%). The risk of death was higher among those who had typical chest CT for COVID-19 (OR 3.47; 95% CI 1.14\u20138.98) and those who had a severity of score higher than 18 (OR 1.89; 95% CI 1.07\u20133.34). Also, presence of consolidation (\n                      <jats:italic>P<\/jats:italic>\n                      value 0.040), pleural effusion (\n                      <jats:italic>P<\/jats:italic>\n                      value 0.000), centrilobular nodules (\n                      <jats:italic>P<\/jats:italic>\n                      value 0.013), and architectural distortion (\n                      <jats:italic>P<\/jats:italic>\n                      value 0.005) were associated with a poorer prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Less than half of COVID-19 patients with a history of cancer had typical imaging features of COVID-19. Radiologists should be aware of atypical, rare, or subtle chest CT findings in patients with pre-existing cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-023-00984-w","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T12:02:51Z","timestamp":1675684971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of chest CT scan in patients with preexisting cancer and COVID-19 pneumonia"],"prefix":"10.1186","volume":"23","author":[{"given":"Faezeh","family":"Khorasanizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soori","family":"Kaviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadi","family":"Salamroudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monireh Sadat","family":"Seyyedsalehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Gity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazem","family":"Zendehdel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"984_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100339","volume":"27","author":"SA Mousavi","year":"2021","unstructured":"Mousavi SA, Rostami T, Kiumarsi A, Rad S, Rostami M, Motamedi F, et al. COVID-19 and cancer: a comparative case series. Cancer Treat Res Commun. 2021;27: 100339.","journal-title":"Cancer Treat Res Commun"},{"issue":"3","key":"984_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335\u20137.","journal-title":"Lancet Oncol"},{"issue":"18","key":"984_CR3","first-page":"1775","volume":"323","author":"G Onder","year":"2020","unstructured":"Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775\u20136.","journal-title":"JAMA"},{"issue":"10241","key":"984_CR4","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","volume":"395","author":"LY Lee","year":"2020","unstructured":"Lee LY, Cazier J-B, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. The Lancet. 2020;395(10241):1919\u201326.","journal-title":"The Lancet"},{"key":"984_CR5","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1148\/radiol.2020200432","volume":"296","author":"Y Fang","year":"2020","unstructured":"Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;296:e115\u20137.","journal-title":"Radiology"},{"issue":"11","key":"984_CR6","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s11604-020-01010-7","volume":"38","author":"M Cellina","year":"2020","unstructured":"Cellina M, Orsi M, Valenti Pittino C, Toluian T, Oliva G. Chest computed tomography findings of COVID-19 pneumonia: pictorial essay with literature review. Jpn J Radiol. 2020;38(11):1012\u20139.","journal-title":"Jpn J Radiol"},{"key":"984_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejca.2020.05.028","volume":"135","author":"S Assaad","year":"2020","unstructured":"Assaad S, Avrillon V, Fournier M-L, Mastroianni B, Russias B, Swalduz A, et al. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR. Eur J Cancer. 2020;135:251\u20139.","journal-title":"Eur J Cancer"},{"issue":"5","key":"984_CR8","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.2214\/AJR.20.22976","volume":"214","author":"W Zhao","year":"2020","unstructured":"Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol. 2020;214(5):1072\u20137.","journal-title":"AJR Am J Roentgenol"},{"key":"984_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/RTI.0000000000000524","volume":"35","author":"S Simpson","year":"2020","unstructured":"Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. J Thorac Imaging. 2020;35:219\u201327.","journal-title":"J Thorac Imaging"},{"key":"984_CR10","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3389\/fonc.2020.01560","volume":"10","author":"T Ramtohul","year":"2020","unstructured":"Ramtohul T, Cabel L, Paoletti X, Chiche L, Moreau P, Noret A, et al. Quantitative CT extent of lung damage in COVID-19 pneumonia is an independent risk factor for inpatient mortality in a population of cancer patients: a prospective study. Front Oncol. 2020;10:1560.","journal-title":"Front Oncol"},{"key":"984_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clinimag.2020.06.004","volume":"67","author":"S Katal","year":"2020","unstructured":"Katal S, Aghaghazvini L, Gholamrezanezhad A. Chest-CT findings of COVID-19 in patients with pre-existing malignancies; a pictorial review. Clin Imaging. 2020;67:121\u20139.","journal-title":"Clin Imaging"},{"key":"984_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.redii.2022.100004","volume":"1","author":"S Bourdoncle","year":"2022","unstructured":"Bourdoncle S, Eche T, McGale J, Yiu K, Partouche E, Yeh R, et al. Investigating of the role of CT scan for cancer patients during the first wave of COVID-19 pandemic. Res Diagn Interv Imaging. 2022;1: 100004.","journal-title":"Res Diagn Interv Imaging"},{"key":"984_CR13","first-page":"47","volume":"27","author":"M Mehrnahad","year":"2022","unstructured":"Mehrnahad M, Davoudi S, Sofian M, Almasi-Hashiani A, Safi F, Tabatabaie M. Comparison of CT Scan Findings of COVID-19 Pneumonia in Patients with and without cancer. Trauma Mon. 2022;27:47\u201353.","journal-title":"Trauma Mon"},{"key":"984_CR14","doi-asserted-by":"crossref","unstructured":"Mahdavi A, Khalili N, Davarpanah AH, Faghihi T, Mahdavi A, Haseli S, et al. Radiologic management of COVID-19: preliminary experience of the Iranian Society of Radiology COVID-19 Consultant Group (ISRCC). Iran J Radiol. 2020;17(2).","DOI":"10.5812\/iranjradiol.102324"},{"issue":"3","key":"984_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10354-022-00914-5","volume":"172","author":"A Aziz-Ahari","year":"2022","unstructured":"Aziz-Ahari A, Keyhanian M, Mamishi S, Mahmoudi S, Bastani EE, Asadi F, et al. Chest CT severity score: assessment of COVID-19 severity and short-term prognosis in hospitalized Iranian patients. Wien Med Wochenschr. 2022;172(3):77\u201383.","journal-title":"Wien Med Wochenschr"},{"key":"984_CR16","doi-asserted-by":"crossref","unstructured":"Seyyedsalehi MS, Rahmati M, Ghalehtaki R, Nahvijou A, Eslami B, Shaka Z, et al. Hospital and post-discharge mortality in COVID-19 patients with a preexisting cancer diagnosis in Iran. 2022.","DOI":"10.21203\/rs.3.rs-2259495\/v1"},{"issue":"7","key":"984_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1158\/2159-8290.CD-20-0516","volume":"10","author":"V Mehta","year":"2020","unstructured":"Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital systemcase fatality rate of cancer patients with COVID-19. Cancer Discov. 2020;10(7):935\u201341.","journal-title":"Cancer Discov"},{"issue":"6","key":"984_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10140-020-01863-5","volume":"27","author":"CS Barbosa","year":"2020","unstructured":"Barbosa CS, Chaves GWOG, de Oliveira CV, Bachion GH, Chi CK, Cerri GG, et al. COVID-19 pneumonia in the emergency department: correlation of initial chest CT findings with short-term outcome. Emerg Radiol. 2020;27(6):691\u20139.","journal-title":"Emerg Radiol"},{"issue":"4","key":"984_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/jnci\/djaa168","volume":"113","author":"H Zhang","year":"2021","unstructured":"Zhang H, Han H, He T, Labbe KE, Hernandez AV, Chen H, et al. Clinical characteristics and outcomes of COVID-19\u2013infected cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2021;113(4):371\u201380.","journal-title":"J Natl Cancer Inst"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-00984-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-023-00984-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-00984-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T12:07:29Z","timestamp":1675685249000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-023-00984-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["984"],"URL":"https:\/\/doi.org\/10.1186\/s12880-023-00984-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1977250\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"assertion":[{"value":"19 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the study\u2019s retrospective nature, the Ethics Committee of Teheran University of Medical Sciences has approved the retrospective study (the Internal Registration Number was IR.TUMS.IKHC.REC.1399.984) and waived the requirements for consent to participate and informed consent. We confirmed that all methods were carried out per the 2002 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}